Therapeutic Potential Of Cord Blood Stem Cells Enhanced With New Technology
Monday, June 9, 2008 - 22:35
in Health & Medicine
A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research.
Read the whole article on Science Daily
More from Science Daily
Related
- New technology enhances therapeutic potential of cord blood stem cellsFri, 6 Jun 2008, 11:15:42 EDT
- Clinical trial demonstrates safety of pre-transplant expansion of umbilical cord blood stem cellsMon, 8 Dec 2008, 16:31:07 EST
- Unrelated and mismatched cord blood transplantation can still help children with deadly conditionsFri, 13 Feb 2009, 11:50:25 EST
- U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrenceFri, 13 Nov 2009, 18:44:36 EST
- Umbilical cord blood as a readily available source for off-the-shelf, patient-specific stem cellsThu, 1 Oct 2009, 12:54:11 EDT